GAM
CEROW

Gritstone Asset Management’s CERo Therapeutics Warrants CEROW Stock Holding History

Gritstone Asset Management’s Portfolio CEROW Stock Details CEROW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		$1.22K Hold
17,014
– – ﹤0.01% 118
2023
Q2 		$1.04K Hold
17,014
– – ﹤0.01% 126
2023
Q1 		$682 Hold
17,014
– – ﹤0.01% 167
2022
Q4 		$733 Buy
+17,014
New +$895 ﹤0.01% 201

Other funds holding CEROW

PC
Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return
SCM
Segantii Capital Management Hong Kong $1.54B AUM 16.73% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.71B AUM 64.83% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 77.9% 1-Year Est. Return
CF
Cantor Fitzgerald New York $6.78B AUM 29.01% 1-Year Est. Return
SCM
Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return

Gritstone Asset Management's CEROW Position: Q3 2023 in Review

Gritstone Asset Management held its CERo Therapeutics Warrants (CEROW) position steady in Q3 2023 at 17,014 shares worth $1.22K. The position accounts for ﹤0.01% of the portfolio, ranked #118.

Gritstone Asset Management first reported a position in CEROW in Q4 2022 and has held it in 4 quarters since. 43 funds tracked by Wall St. Rank hold CEROW as of Q3 2023.

  • Gritstone Asset Management held 17,014 shares of CERo Therapeutics Warrants worth $1.22K as of Q3 2023.
  • Gritstone Asset Management left its CERo Therapeutics Warrants share count unchanged in Q3 2023.
  • CERo Therapeutics Warrants made up ﹤0.01% of Gritstone Asset Management's portfolio in Q3 2023, its #118 holding.
  • Gritstone Asset Management first reported a position in CERo Therapeutics Warrants in Q4 2022 and has held it in 4 quarters since.
  • 43 funds tracked by Wall St. Rank held CERo Therapeutics Warrants as of Q3 2023.

Based on Gritstone Asset Management's 13F filing for Q3 2023, filed 20 Oct 2023.